Division of Nephrology, Department of Internal Medicine, University Hospital Leipzig, Liebigstr, 2004103, Leipzig, Germany.
Bioscientia, Institute of Human Genetics, Ingelheim, Germany.
BMC Nephrol. 2019 Sep 2;20(1):340. doi: 10.1186/s12882-019-1523-7.
Kidney transplantation is the treatment of choice in end-stage renal disease due to Alport syndrome (AS). However, the chances of finding an adequate living-related donor in AS are much worse compared to non-heritable conditions. Successful cases of related living-donor transplantation mostly refer to X-linked AS but are rarely reported in genetically confirmed autosomal AS.
We describe the outcome of an exceptional AB0-incompatible kidney donation from father to son in a family with altered COL4A3. While decision-making was based on extensive clinical donor evaluation prior to transplantation, we analyzed the underlying genetic background in retrospect and associated these findings with the phenotype in all available family members. While biallelic COL4A3 variants caused autosomal recessive AS (ARAS) in the son (recipient), heterozygous family members, including the father (donor), showed minimal renal involvement and high-frequency sensorineural hearing impairment later in life indicating mild autosomal dominant Alport syndrome (ADAS). The recipient's successful participation in the European and World Transplant Games is a testament to the positive outcome of transplantation.
In summary, living-related donor transplantation may be successful in autosomal AS, provided that thorough clinical and genetic evaluation of potential donors is performed. However, unrelated kidney transplantation should be given priority upon unpredictable genetic risk. Individual genetic variant interpretation is an important component of personalized donor assessment and will help to better predict genetic risk in the future.
由于 Alport 综合征(AS),肾移植是终末期肾病的首选治疗方法。然而,与非遗传性疾病相比,在 AS 中找到合适的活体亲属供体的机会要差得多。相关活体供体移植的成功案例主要涉及 X 连锁 AS,但在遗传确认的常染色体 AS 中很少有报道。
我们描述了一个特殊的 ABO 不相容的肾从父亲到儿子的活体供体移植的结果,这个家庭的 COL4A3 发生了改变。虽然在移植前进行了广泛的临床供体评估,但我们回顾性地分析了潜在的遗传背景,并将这些发现与所有可用的家庭成员的表型相关联。虽然双等位基因 COL4A3 变体导致儿子(受者)的常染色体隐性 AS(ARAS),但杂合子家庭成员,包括父亲(供体),在以后的生活中表现出轻微的肾脏受累和高频感音神经性听力损失,表明轻度常染色体显性 Alport 综合征(ADAS)。受者成功参加欧洲和世界移植运动会证明了移植的积极结果。
总之,在进行彻底的临床和遗传评估后,活体亲属供体移植可能在常染色体 AS 中取得成功。然而,在不可预测的遗传风险下,应优先考虑无关肾移植。个体遗传变异的解释是个性化供体评估的重要组成部分,有助于更好地预测未来的遗传风险。